Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(
1
)
Home
|
Portfolio
|
Market Currents
|
Investing Ideas
|
Dividends & Income
|
ETFs
|
Macro View
|
ALERTS
|
PRO
14
people get NTII articles and Market Currents by email alert.
Get email alerts on NTII
»
NTII
Neurobiological Technologies, Inc.
5/22/2013, 6:46 AM ET
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
14
people get NTII articles and Market Currents by email alert.
Get email alerts on NTII
»
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
Neurobiological Tech Provides an Exit Opportunity
Greenbackd
•
Mon, May 11, 2009
NTII on the Block - and Trading at Discount
Greenbackd
•
Tue, Mar 31, 2009
Performance and Update of Our Undervalued Assets Portfolio
Greenbackd
•
Mon, Mar 2, 2009
•
2 Comments
Neurobiological Technologies Could Go the Way of Avigen
Greenbackd
•
Mon, Feb 23, 2009
Neurobiological Technologies, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript
Tue, Sep 16, 2008
Neurobiological Technologies F2Q07 (Qtr End 1/31/07) Earnings Call Transcript
Mon, Feb 12, 2007
Biotech Day In Review: Sanofi Loses Lovenox Patent
Centient Biotech Investor
•
Sun, Feb 11, 2007
Biotech Stocks Day-in-Review: BioCryst Begins Pivotal Trial of Fodosine
Centient Biotech Investor
•
Wed, Jan 17, 2007
To learn more about Seeking Alpha Pro, click
here
.
Neurobiological Tech Provides an Exit Opportunity
Greenbackd
•
Mon, May 11, 2009
NTII on the Block - and Trading at Discount
Greenbackd
•
Tue, Mar 31, 2009
Performance and Update of Our Undervalued Assets Portfolio
Greenbackd
•
Mon, Mar 2, 2009
•
2 Comments
Neurobiological Technologies Could Go the Way of Avigen
Greenbackd
•
Mon, Feb 23, 2009
Biotech Day In Review: Sanofi Loses Lovenox Patent
Centient Biotech Investor
•
Sun, Feb 11, 2007
Biotech Stocks Day-in-Review: BioCryst Begins Pivotal Trial of Fodosine
Centient Biotech Investor
•
Wed, Jan 17, 2007
Neurobiological Technologies, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript
Tue, Sep 16, 2008
Neurobiological Technologies F2Q07 (Qtr End 1/31/07) Earnings Call Transcript
Mon, Feb 12, 2007
There are no News articles on NTII.
NTII
vs. ETF Alternatives
Company Description
Currently, there's no company description for NTII.
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
All
|
Earnings
|
Dividends
|
M&A
|
On the move
Monday, December 17, 2012, 7:50 AM
Neurobiological Technologies (
NTII
)
declares special dividend of $0.05/share. For shareholders of record Dec. 20. Payable Dec. 27. Ex-div date Dec. 18. (
PR
)
Comment!
[
Dividends
]
NTII StockTalk
|
Twitter NTII
|
Twitter $NTII
|
NTII Instablogs
14
people get NTII articles and Market Currents by email alert.
Get email alerts on NTII
»